Johanna Elisabeth Maria Groener - Publications

Affiliations: 
Medical Biochemistry University of Amsterdam, Amsterdam, Netherlands 
 1978 Veterinary Biochemistry Utrecht University, Utrecht, Netherlands 

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 van Dussen L, Hendriks EJ, Groener JE, Boot RG, Hollak CE, Aerts JM. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy. Journal of Inherited Metabolic Disease. 37: 991-1001. PMID 24831585 DOI: 10.1007/s10545-014-9711-x  0.49
2013 Gold H, Mirzaian M, Dekker N, Joao Ferraz M, Lugtenburg J, Codée JD, van der Marel GA, Overkleeft HS, Linthorst GE, Groener JE, Aerts JM, Poorthuis BJ. Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry. Clinical Chemistry. 59: 547-56. PMID 23237761 DOI: 10.1373/Clinchem.2012.192138  0.28
2012 Rombach SM, Aerts JM, Poorthuis BJ, Groener JE, Donker-Koopman W, Hendriks E, Mirzaian M, Kuiper S, Wijburg FA, Hollak CE, Linthorst GE. Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome. Plos One. 7: e47805. PMID 23094092 DOI: 10.1371/journal.pone.0047805  0.476
2012 Rombach SM, van den Bogaard B, de Groot E, Groener JE, Poorthuis BJ, Linthorst GE, van den Born BJ, Hollak CE, Aerts JM. Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine. Hypertension. 60: 998-1005. PMID 22868390 DOI: 10.1161/HYPERTENSIONAHA.112.195685  0.505
2012 Hollak CEM, de Sonnaville ESV, Cassiman D, Linthorst GE, Groener JE, Morava E, Wevers RA, Mannens M, Aerts JMFG, Meersseman W, Akkerman E, Niezen-Koning KE, Mulder MF, Visser G, Wijburg FA, et al. Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: Disease spectrum and natural course in attenuated patients Molecular Genetics and Metabolism. 107: 526-533. PMID 22818240 DOI: 10.1016/J.Ymgme.2012.06.015  0.501
2012 van Dussen L, Cox TM, Hendriks EJ, Morris E, Akkerman EM, Maas M, Groener JE, Aerts JM, Deegan PB, Hollak CE. Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes. Haematologica. 97: 1850-4. PMID 22773601 DOI: 10.3324/Haematol.2011.059071  0.512
2011 Smid BE, Rombach SM, Aerts JM, Kuiper S, Mirzaian M, Overkleeft HS, Poorthuis BJ, Hollak CE, Groener JE, Linthorst GE. Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients. Orphanet Journal of Rare Diseases. 6: 69. PMID 22041095 DOI: 10.1186/1750-1172-6-69  0.52
2011 Aerts JM, Boot RG, van Eijk M, Groener J, Bijl N, Lombardo E, Bietrix FM, Dekker N, Groen AK, Ottenhoff R, van Roomen C, Aten J, Serlie M, Langeveld M, Wennekes T, et al. Glycosphingolipids and insulin resistance. Advances in Experimental Medicine and Biology. 721: 99-119. PMID 21910085 DOI: 10.1007/978-1-4614-0650-1_7  0.507
2011 Dekker N, van Dussen L, Hollak CE, Overkleeft H, Scheij S, Ghauharali K, van Breemen MJ, Ferraz MJ, Groener JE, Maas M, Wijburg FA, Speijer D, Tylki-Szymanska A, Mistry PK, Boot RG, et al. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood. 118: e118-27. PMID 21868580 DOI: 10.1182/blood-2011-05-352971  0.572
2011 van Dussen L, Lips P, Everts VE, Bravenboer N, Jansen ID, Groener JE, Maas M, Blokland JA, Aerts JM, Hollak CE. Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease. The Journal of Clinical Endocrinology and Metabolism. 96: 2194-205. PMID 21543432 DOI: 10.1210/jc.2011-0162  0.464
2011 Aerts JM, Kallemeijn WW, Wegdam W, Joao Ferraz M, van Breemen MJ, Dekker N, Kramer G, Poorthuis BJ, Groener JE, Cox-Brinkman J, Rombach SM, Hollak CE, Linthorst GE, Witte MD, Gold H, et al. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. Journal of Inherited Metabolic Disease. 34: 605-19. PMID 21445610 DOI: 10.1007/s10545-011-9308-6  0.487
2011 Groener JE, Serlie MJ, Poppema A, Mirzaian M, Aerts JM. Ceramide in lipid emulsions used in parenteral nutrition: an innocent bystander? Jpen. Journal of Parenteral and Enteral Nutrition. 35: 270-1. PMID 21378257 DOI: 10.1177/0148607110381404  0.508
2010 Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, Kuiper S, Vd Bergh Weerman MA, Groener JE, Poorthuis BJ, Hollak CE, Aerts JM. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochimica Et Biophysica Acta. 1802: 741-8. PMID 20471476 DOI: 10.1016/j.bbadis.2010.05.003  0.519
2010 Boomsma JM, van Dussen L, Wiersma MG, Groener JE, Aerts JM, Maas M, Hollak CE. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study. Blood Cells, Molecules & Diseases. 44: 181-7. PMID 20074983 DOI: 10.1016/j.bcmd.2009.12.006  0.507
2009 de Fost M, Langeveld M, Franssen R, Hutten BA, Groener JE, de Groot E, Mannens MM, Bikker H, Aerts JM, Kastelein JJ, Hollak CE. Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease. Atherosclerosis. 204: 267-72. PMID 18842264 DOI: 10.1016/j.atherosclerosis.2008.08.027  0.327
2003 Aguilera B, Ghauharali-van der Vlugt K, Helmond MT, Out JM, Donker-Koopman WE, Groener JE, Boot RG, Renkema GH, van der Marel GA, van Boom JH, Overkleeft HS, Aerts JM. Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. The Journal of Biological Chemistry. 278: 40911-6. PMID 12890686 DOI: 10.1074/Jbc.M301804200  0.307
1998 Meijer GW, Groener JE, Beynen AC, Van Tol A. Lowering of serum cholesteryl ester transfer protein--but not lecithin:cholesterol acyltransferase--activity levels by hypocholesterolemic drugs in the rabbit. Cardiovascular Drugs and Therapy. 12: 13-8. PMID 9607128 DOI: 10.1023/a:1007773011736  0.344
1997 Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes. 46: 2082-7. PMID 9392500 DOI: 10.2337/diab.46.12.2082  0.724
1996 Meijer GW, Groener JE, Beynen AC, Van Tol A. CETP activity in liver perfusates and plasma from rabbits hypo- or hyperresponsive to dietary cholesterol. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 114: 403-7. PMID 8840515 DOI: 10.1016/0305-0491(96)00070-3  0.331
1993 Meijer GW, Demacker PN, Van Tol A, Groener JE, Van der Palen JG, Stalenhoef AF, Van Zutphen LM, Beynen AC. Plasma activities of lecithin:cholesterol acyltransferase, lipid transfer proteins and post-heparin lipases in inbred strains of rabbits hypo- or hyper-responsive to dietary cholesterol. The Biochemical Journal. 293: 729-34. PMID 8352738 DOI: 10.1042/bj2930729  0.371
1991 Dullaart RP, Groener JE, Dikkeschei BD, Erkelens DW, Doorenbos H. Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care. 14: 338-41. PMID 2060438 DOI: 10.2337/diacare.14.4.338  0.739
1990 Dullaart RP, Hoogenberg K, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins. European Journal of Clinical Investigation. 20: 581-7. PMID 2127747 DOI: 10.1111/j.1365-2362.1990.tb01904.x  0.752
1989 Dullaart RP, Groener JE, van Wijk H, Sluiter WJ, Erkelens DW. Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men. Arteriosclerosis (Dallas, Tex.). 9: 614-22. PMID 2783075 DOI: 10.1161/01.atv.9.5.614  0.761
1989 Dullaart RP, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids. Diabetologia. 32: 14-9. PMID 2707515 DOI: 10.1007/BF00265398  0.736
1987 Dullaart RP, Groener JE, Erkelens DW. Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro. European Journal of Clinical Investigation. 17: 241-8. PMID 3113969 DOI: 10.1111/j.1365-2362.1987.tb01243.x  0.744
1985 Groener JE, Jacobs DM, van Rozen AJ, Erkelens DW. Diet, lipoproteins and cholesteryl ester transfer activity in hyperlipidaemic subjects. Clinical Nutrition (Edinburgh, Scotland). 4: 35-8. PMID 16831701 DOI: 10.1016/0261-5614(85)90035-4  0.611
1980 Groener JE, Klein W, Van Golde LM. The effect of fasting and refeeding on the composition and synthesis of triacylglycerols, phosphatidylcholines, and phosphatidylethanolamines in rat liver. Archives of Biochemistry and Biophysics. 198: 287-95. PMID 507846 DOI: 10.1016/0003-9861(79)90421-1  0.651
1979 Geelen MJ, Groener JE, De Haas CG, Van Golde LM. Influence of glucagon on the synthesis of phosphatidylcholines and phosphatidylethanolamines in monolayer cultures of rat hepatocytes. Febs Letters. 105: 27-30. PMID 488344 DOI: 10.1016/0014-5793(79)80880-7  0.64
1978 Geelen MJ, Groener JE, de Haas CG, Wisserhof TA, van Golde LM. Influence of insulin and glucagon on the synthesis of glycerolipids in rat hepatocytes. Febs Letters. 90: 57-60. PMID 658442 DOI: 10.1016/0014-5793(78)80297-X  0.644
1978 Groener JE, van Golde LM. Utilization of exogenously added and endogenously synthesized fatty acids for glycerolipids synthesis in isolated rat hepatocytes. Biochimica Et Biophysica Acta. 529: 88-95. PMID 638182 DOI: 10.1016/0005-2760(78)90106-6  0.638
1977 Groener JE, van Golde LM. Effect of fasting and feeding a high-sucrose, fat-free diet on the synthesis of hepatic glycerolipids in vivo and in isolated hepatocytes. Biochimica Et Biophysica Acta. 487: 105-14. PMID 870053 DOI: 10.1016/0005-2760(77)90047-9  0.68
Show low-probability matches.